Claims
- 1. 1-[N2-((S)-ethoxycarbonyl)-3-phenylpropyl)-N6-trifluoroacetyl]-L-lysyl-L-proline (LPE) of formula (I) with reflexes at6.7241 9.4851 11.9034 16.3073 17.8722 (2 theta), and having no individual organic solvent present at a residual level greater than 598 mg/kg, said residual level being determined after the LPE has dried for 4 h in an oil pump vacuum at room temperature.
- 2. LPE of formula (I) produced from an aqueous solution in an LPE production process by extraction and subsequent crystallization, comprising using a solvent or solvent mixture, excluding methyl tert, butyl ether, to extract the LPE of formula (1) which solvent or solvent mixture is also a main constituent of a solvent or solvent mixture used for the crystallization wherein the crystallization step yields LPE of formula (1) with reflexes at6.7241 9.4851 11.9034 16.3073 17.8722 (2 theta), and having no individual organic solvent present at a residual level greater than 598 mg/kg, said residual level being determined after the LPE has dried for 4 h in an oil pump vacuum at room temperature.
Priority Claims (1)
Number |
Date |
Country |
Kind |
197 32 839 |
Jul 1997 |
DE |
|
CROSS REFERENCE TO RELATED APPLICATION
This is a division of application Ser. No. 08/951,579, filed Oct. 16, 1997, now U.S. Pat. No. 5,907,004.
US Referenced Citations (7)
Foreign Referenced Citations (3)
Number |
Date |
Country |
43 31 540 |
Sep 1993 |
DE |
0 523 449 |
Jan 1993 |
EP |
0 645 398 |
Mar 1995 |
EP |
Non-Patent Literature Citations (1)
Entry |
Hemial Abstracts, vol. 126, No. 4 (Jan. 27, 1997), Abstract No. 47560, M. Kurauchi et al., “Method for producing dipeptide derivative as intermediate for antihypertensive agent”. |